SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3557 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2907Black scenario! China did not open border (Asia as well), and will not until theMiljenko Zuanic-4/18/2020
2906I guess there could be another scenario: US and EU recover and stop trade with Biotechwantabe-4/18/2020
2905Well if it last 18months- Stock market crash, Starvation, death, Suicides... OnBiotechwantabe-4/18/2020
2904<Overall market anticipating recovery <6m Baby boom after recovery. :)>Miljenko Zuanic-4/18/2020
2903Current products firing on all cylinders: Eylea- reduced competition, continuedBiotechwantabe-4/18/2020
2902What's driving the current surge? I can't believe the market as whole iFelix B-4/17/2020
2901Are you possibly thinking of AGN’s abicipar pegol, which is currently under FDA DewDiligence_on_SI-4/12/2020
2900Ah yes, probably something whose phase 2 will prove a mirage in phase 3, much liCuttingEdge Bio-4/12/2020
2899What is the next threat in the clinic Eylea now that this has passed? I thoughtFelix B-4/10/2020
2898NVS concedes that Beovu has new safety problem: investorshub.advfn.comDewDiligence_on_SI14/9/2020
2897Great interview with Yan (Thanks Matthew Herper): statnews.com Anyone interesteMiljenko Zuanic14/8/2020
2896investor.regeneron.com investor.regeneron.com I guess they are still undecidedBiotechwantabe-4/6/2020
2895BACKGROUNDRheumatoid arthritis (RA) is an autoimmune disease characterized by chBiotechwantabe14/2/2020
2894Vir/anly- ace2 investors.vir.bioBiotechwantabe-4/2/2020
2893"Hydroxychloroquine with Zn may be good alternative, but this is for early CuttingEdge Bio-4/2/2020
2892Hydroxychloroquine with Zn may be good alternative, but this is for early onset Miljenko Zuanic-4/1/2020
2891Notice that this trial is not in the US. My understanding is favi is made by FuCuttingEdge Bio-4/1/2020
2890There is a difference. Ebola had >50% mortality, and the other treatment beiCuttingEdge Bio-4/1/2020
2889Hmmm interesting in choice of different placebo arms...Felix B-4/1/2020
2888Combination where Favipiravir (antiviral with some activity demonstrated in few Miljenko Zuanic-4/1/2020
2887<It is essential, as this is the only thing that proves the treatment is workMiljenko Zuanic-4/1/2020
2886George said publicly they will have results already by end of April. A placebo cCuttingEdge Bio14/1/2020
2885Interesting article on potentially *negative* outcome for the Ab-RBD spike proteMiljenko Zuanic14/1/2020
2884REGN expanded sites (outside NY state) very fast. Good! They can enroll 400 subjMiljenko Zuanic-4/1/2020
2883clinicaltrials.gov Cov trialBiotechwantabe-3/31/2020
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):